Fair Value Distribution — percentile bands
100.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
1.4%/yr
±11.7% · revenue growth to justify current price
FCF-Based Reverse DCF
-5.3%/yr
±2.4% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States.
No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.
No analysis yet
No analysis yet
CI undergoes transformation divesting Medicare business while launching rebate-free PBM model. Regulatory headwinds (2028 PBM compensation reform) offset by operational scale in integrated benefits.